Zobrazeno 1 - 6
of 6
pro vyhledávání: '"b-adrenoblockers"'
Autor:
M. V. Leonova, L. L. Steinberg, Yu. B. Belousov, D. V. Belyavskaya, O. I. Vydrina, E. Yu. Pasternak, D. Yu. Belousov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 59-66 (2015)
Aim. To conduct the new stage of pharmaco-epidemiologic study of AH — PIFAGOR IV to study the structure and prevalence of various classes of antihypertensive drugs usage (ADU) in clinical practice. Material and methods. The study was conducted with
Externí odkaz:
https://doaj.org/article/8b0ad6a0bad944f0add4b442736cfea7
Autor:
G N Gorokhovskaya, V L Yun
Publikováno v:
Системные гипертензии, Vol 11, Iss 3, Pp 29-33 (2014)
This article examines the modern approach to the treatment of arterial hypertension as one of the most important medical and social problems in the developed world, characterised by a high prevalence high risk of cardiovascular complications and occu
Externí odkaz:
https://doaj.org/article/103a234313074baaa5d32d7b3d318c30
Autor:
M. G Bubnova
Publikováno v:
КардиоСоматика, Vol 4, Iss 2, Pp 27-36 (2013)
The paper describes a clinical case of developing coronary heart disease in a young man, by analyzing the specific features of the disease and performed therapy. It discusses the management of this man according to the current recommendations and evi
Externí odkaz:
https://doaj.org/article/7a4f33b808d54c53bf7c82a29d95c5b9
Autor:
N B Perepech, V D Shurygina
Publikováno v:
Системные гипертензии, Vol 9, Iss 4, Pp 22-27 (2012)
The paper discusses the aspects of using b-adrenoblockers in the treatment of patients with arterial hypertension (AH). It discusses the reasons why United Kingdom experts have excluded b-adrenoblockers from the list of first-line antihypertensive dr
Externí odkaz:
https://doaj.org/article/0d1191ce97fc4ad0946f4851f4e88f44
Autor:
V D Shurygina, N. B Perepech
Publikováno v:
Системные гипертензии, Vol 9, Iss 4, Pp 22-27 (2012)
The paper discusses the aspects of using b-adrenoblockers in the treatment of patients with arterial hypertension (AH). It discusses the reasons why United Kingdom experts have excluded b-adrenoblockers from the list of first-line antihypertensive dr
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 7, Pp 88-92 (1970)
The authors review the current evidence on the effectiveness of a highly selective b-adrenoblocker bisoprolol in the treatment of arterial hypertension and/or coronary heart disease. The issues of bisoprolol therapy in the specific clinical subgroups
Externí odkaz:
https://doaj.org/article/a695972fea4d43078fbf38fc336993f5